Domestic general government health expenditure in Europe & Central Asia
Europe & Central Asia: Domestic general government health expenditure was 7.0% in 2023. ▲ Rising
Domestic general government health expenditure in Europe & Central Asia, 2000–2023
Source: Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO). Measured in % of GDP.
Analysis
In 2023, domestic general government health expenditure in Europe & Central Asia stood at 7.0%.
The figure is down 3.3% on the previous year and up 7.3% over ten years.
Over the whole period, domestic general government health expenditure in Europe & Central Asia peaked at 7.9% in 2020 and was at its lowest, 5.8%, in 2000.
That places Europe & Central Asia 7th out of 47 groups with data for 2023, putting it in the top quarter.
The long-run direction has been consistently rising across the 24 years of available data.
Domestic general government health expenditure in Europe & Central Asia, year by year
| Year | % of GDP | Change |
|---|---|---|
| 2000 | 5.8% | — |
| 2001 | 6.0% | +2.5% |
| 2002 | 6.2% | +3.5% |
| 2003 | 6.3% | +2.4% |
| 2004 | 6.3% | -0.4% |
| 2005 | 6.3% | +0.1% |
| 2006 | 6.2% | -1.1% |
| 2007 | 6.1% | -1.6% |
| 2008 | 6.3% | +2.3% |
| 2009 | 6.9% | +10.1% |
| 2010 | 6.7% | -3.0% |
| 2011 | 6.6% | -2.5% |
| 2012 | 6.5% | -0.2% |
| 2013 | 6.6% | +0.3% |
| 2014 | 6.6% | +1.3% |
| 2015 | 6.7% | +1.0% |
| 2016 | 6.8% | +1.2% |
| 2017 | 6.7% | -1.2% |
| 2018 | 6.7% | +0.5% |
| 2019 | 6.8% | +0.7% |
| 2020 | 7.9% | +16.8% |
| 2021 | 7.8% | -1.4% |
| 2022 | 7.3% | -7.0% |
| 2023 | 7.0% | -3.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6.3% | 5.8% | 6.9% | 10 |
| 2010s | 6.7% | 6.5% | 6.8% | 10 |
| 2020s | 7.5% | 7.0% | 7.9% | 4 |
Countries ranked near Europe & Central Asia
More health data for Europe & Central Asia
- Population ages 45-49, female, annual growth rate 0.9265 % change on previous year (2025)
- Population ages 45-49, male, per capita 0.0339 units per person (2025)
- Population ages 45-49, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per capita 0.0299 units per person (2025)
- Population ages 45-49, male, annual growth rate 1.04 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0346 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, male, annual growth rate 0.6344 % change on previous year (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, per capita 0.0352 units per person (2025)
Frequently asked questions
- What is domestic general government health expenditure in Europe & Central Asia?
- Domestic general government health expenditure in Europe & Central Asia was 7.0% in 2023, according to Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO).
- What is the highest domestic general government health expenditure recorded in Europe & Central Asia?
- The highest recorded value was 7.9% in 2020.
- What is the lowest domestic general government health expenditure recorded in Europe & Central Asia?
- The lowest recorded value was 5.8% in 2000.
- How does Europe & Central Asia rank for domestic general government health expenditure?
- Europe & Central Asia ranks 7th out of 47 groups with data for 2023.
- Is domestic general government health expenditure rising or falling in Europe & Central Asia?
- Over the last ten years it is up 7.3%. The long-run trend across the full record is rising.
- Where does this Europe & Central Asia data come from?
- The figures come from Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO), published as part of Domestic general government health expenditure (% of GDP). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Public expenditure on health from domestic sources as a share of the economy as measured by GDP.